.jpg)
Home
Conference Programme
Conference Programme
Conference Programme
Please visit us again or follow us on Facebook http://www.facebook.com/aids2011
for more updates on the Conference Programme.
Download programme
Tuesday, May 24th, 2011 |
||
|
10.00 - 19.00 |
||
| 10.00 - 18.00 | Site-Visits | |
|
|
HIV in prisons: interventions in prisons for drug users and HIV-positive inmates Harm reduction: rehabilitation and harm reduction services for drug users HIV and TB: directly observed tuberculosis treatment and HIV HIV treatment and care: health care and services for people living with HIV |
|
| 15.00 - 19.00 |
Satellite Workshop on HIV Data Triangulation |
|
Wednesday, May 25th, 2011 |
||
|
8.30 - 19.00 |
REGISTRATION |
|
|
9.30 - 11.00 |
OPENING SESSION |
|
|
Welcome Address |
Toomas Hendrik Ilves, President of the Republic of Estonia Wolfgang Philipp, The Directorate General Health and Consumers of the European Commission, on behalf of the European Commission Igor Sobolev, Estonian Network of People Living with HIV, on behalf of the Community of People Living with HIV |
|
| Chairs |
Hanno Pevkur, Minister of Social Affairs of Estonia Wolfgang Philipp, The Directorate General Health and Consumers of the European Commission |
|
|
Key-note speakers |
HIV in Europe - challenges for 2020 HIV Response in the European Region Health systems and the challenge of HIV/TB in the European Region The economics of HIV: assessing its costs to society and helping with resource allocation and guidelines for prevention and treatment |
|
|
11.00 - 11.30 |
Break |
|
|
11.30 - 12.30 |
PLENARY |
|
|
|
Do we know the needs of the key-populations? |
|
|
Chairs |
Anneli Uusküla, Tartu University, Estonia Pauli Leinikki, National Institute for Health and Welfare, Finland |
|
|
Speakers |
Injecting drug users in Europe: needs and service provision Findings and Recommendations from the Regional Consultation on HIV, men who have sex with men and transgender people in Eastern Europe and Central Asia Community of people living with HIV: needs and expectations |
|
|
12.30 - 14.00 |
Lunch break |
|
|
14.00 - 15.30 |
PLENARY |
|
|
|
Commitment and implementation of HIV prevention and treatment in European Region |
|
|
Moderator |
Ton Coenen, Executive Director, Aids Fonds & Soa Aids, Netherlands |
|
|
Speaker |
Regional responses to HIV: What have we learned by monitoring the Dublin Declaration? |
|
|
Panelists |
Key-note presentation on implementation of the Dublin Declaration on Partnership to fight HIV/AIDS in Europe and Central Asia will be followed by panel discussion. List of panelists to be confirmed. |
|
|
15.30 - 16.00 |
Break |
|
|
16.00 - 17.30 |
PARALLEL SESSIONS |
|
|
|
SESSION I People who inject drugs |
|
|
Chairs |
Lucas Wiessing, EMCDDA Raminta Stuikyte, European AIDS Treatment Group, Lithuania |
|
| Speakers |
The required coverage and impact of syringe exchange programmes to prevent HIV and HCV transmission among IDUs IDU's sexual behaviour in the context of HIV epidemic generalization in Russia Methadone and Buprenorphine for HIV prevention Experience of self-organization New Vector in HIV/AIDS prevention among IDUs Characteristics of injection drug use and HIV spreading in urban and suburb territories: Saint-Petersburg and Leningrad region |
|
|
SESSION II HIV surveillance methodologies |
||
|
Chairs |
Ivana Bozicevic, WHO Collaborating Centre for Capacity Development in HIV Surveillance, School of Medicine, Zagreb, Croatia Olga Varetska, International HIV/AIDS Alliance in Ukraine, Ukraine |
|
| Speakers |
Monitoring the HIV epidemic in real-time: Insights from the United Kingdom's RITA programme European HIV/AIDS surveillance: methodological aspects Using modes of transmission model for HIV data triangulation in Moldova HIV incidence in most at-risk populations in Spain, 2000-2007 |
|
|
13.00 - 17.30 |
||
| 13.00 - 14.00 |
Special session on HIV/AIDS projects funded under EU programmes |
|
| 15.30 - 17.00 |
Correlation Network Workshop "Hepatitis C and drug use - response from practitioners" | |
| 16.00 - 19.00 | Special session on Exploring Private Sector Engagement in HIV Prevention: Lessons, Opportunities, and Challenges. Estonian Business Coalition against HIV | |
| 17.30 - 21.30 | IQhiv Steering Group meeting. IQhiv Initiative (by invitation only) | |
|
19.00 - 22.00 |
OFFICIAL DINNER
|
|
Thursday, May 26th, 2011 |
||
|
09.00 - 10.30 |
PARALLEL SESSIONS |
|
|
|
SESSION III Overcoming obstacles to late presentation for HIV in Europe - the role of HIV testing |
|
|
Chairs |
Jose Gatell, University of Barcelona, Spain Ton Coenen, Executive Director, Aids Fonds & Soa Aids, Netherlands |
|
| Speakers |
Patient and staff attitudes towards routine HIV testing programmes in general healthcare settings in London, UK: the HINTS (HIV in non-traditional settings) study HIV in Europe Study; a pilot feasibility and acceptability study of HIV testing in selected Indicator Conditions HIV testing: increasing uptake and effectiveness in the EU Late Testing, Late Treatment in Eastern Europe and Central Asia: Findings from the PLHIV Stigma Index in Estonia, Moldova, Poland, Turkey and Ukraine Rights of pregnant IDUs in Ukraine: HIV testing and antenatal care |
|
|
|
SESSION IV HIV-TB co-infection. Implications for public health practice |
|
|
Chairs |
Kristiina Salovaara, Finnish Lung Health Association, Finland Manfred Danilovitš, Tartu University Hospital, Estonia |
|
| Speakers |
Infection control of tuberculosis in HIV settings Intensified TB case finding and outreach among hard to reach groups - a pan London experience Isoniazid preventive therapy The situation, challenges and needs of TB in the light of HIV epidemic among IDUs in Romania |
|
|
10.30 - 11.00 |
Break |
|
|
11.00 - 12.30 |
PARALLEL SESSIONS |
|
|
|
SESSION V Access to HIV treatment and care |
|
|
Chairs |
Anna Zakowicz, European AIDS Treatment Group, Belgium Johann Fontaine, Ministry of Health, Germany |
|
| Speakers |
Prioritization: States’ commitments and funding, contradicting national policies, role of PLWH community Access to antiretroviral treatment: pricing, patents, generics, parallel import New European Union member states: challenges and success Implementation of TRIPS flexibilities in Ukraine |
|
|
|
SESSION VI HIV and MSM. How diverse is the situation in Europe |
|
|
Chair |
Ulrich Marcus, Robert Koch Institute, Germany Peter Wiessner, European AIDS Treatment Group, Germany |
|
| Speakers |
Presentation of EMIS data from the Scandinavian countries, the Baltic states, Russia, and Belarus MSM and HIV in Eastern Europe and Central Asia: what is missing and what can be done MSM and HIV in Eastern Europe and Central Asia: are they invisible or we just do not want to see them? HIV testing and associated factors among men who have sex with men in Latvia Prevalence of pharyngeal and rectal gonorrhoea and chlamydia Infections among men who have sex with men in Germany |
|
|
|
SESSION VII Molecular epidemiology and resistance |
|
|
Chairs |
Irja Lutsar, Tartu University, Estonia Jan Albert, Karolinska University Hospital, Sweden |
|
| Speakers |
Use of molecular epidemiological methods in forensic investigation Current state of HIV molecular epidemiology in Russia Molecular epidemiology of HIV infection in Europe Drug resistant mutations and polymorphisms in non-B viruses Molecular tracing of heterosexual HIV-1 transmission in Georgia Dynamics of Two Linked HIV-1 CRF01_AE Outbreaks among Injection Drug Users in Stockholm, Sweden, and Helsinki, Finland |
|
| OPEN STAGE SPECIAL SESSION The Lancet series: HIV and human rights of people who use drugs |
||
| Chair | Tamas Varga, Global Drug Policy Program, Open Society Foundations | |
| Speakers |
Joanne Csete, Department of Population and Family Health Columbia University Mailman School of Public Health New York, NY USA Carl Hart, Columbia University, New York State Psychiatric Institute Patrizia Carrieri, National Institute for Health and Medical Research, France |
|
|
12.30 - 14.30 |
Lunch break Poster Exhibition |
|
| 13.00 - 14.00 |
SPECIAL POSTER SESSION HIV related issues among injecting drug users |
|
| Chairs |
Barbara Broers, University Hospital of Geneva, Switzerland Maria Jose Bravo, Instituto de Salud Carlos III, Centro Nacional de Epidemiología, Spain |
|
| Speakers |
Can non-injecting drug use protect against blood borne viruses among people who inject drugs? Evidence from Tallinn, Estonia and New York City, USA Harm reduction and drug treatment in prison: 15 years experience in Geneva Primary care consultations and HIV counseling and testing in a safe injecting facility in Geneva: an alternative access to care for vulnerable populations Age of first injection, does it matter? Peer-driven interventions - an effective approach for HIV prevention among injecting drug users HIV related risk and preventive behaviours among primary opioid and amphetamine injectors in Latvia and Lithuania |
|
|
14.30 - 16.00 |
PARALLEL SESSIONS |
|
|
|
SESSION VIII Models of care for people who inject drugs |
|
|
Chairs |
Barbara Broers, University Hospital of Geneva, Switzerland Eberhard Shatz, Foundation De REGENBOOG GROEP, Netherlands |
|
| Speakers |
Models of care for IDUs, 30 years of experience in NYC, meeting the changing needs Integrated services for management of co-infections among IDUs (one-stop-shop idea and other solutions) Pharmacological approach to support antiretroviral therapy adherence among IDUs in Russia Georgian model of HIV treatment program and adherence support |
|
|
|
SESSION IX Quality issues in HIV prevention |
|
|
Chairs |
Jarno Habicht, WHO Country Office, Moldova Patrizia Carrieri, National Institute for Health and Medical Research, France |
|
| Speakers |
Quality in HIV prevention How to create a culture which supports development and implementation of evidence based interventions QuaTheDA - quality management of the care for people who inject drugs Applying programmatic monitoring data in order to improve quality of service delivery in care and support programs for PLHIV in Ukraine Usage of electronic database software for management and HIV prevention projects improvement in Ukraine |
|
|
16.00 - 16.30 |
Break |
|
|
16.30 - 18.00 |
PARALLEL SESSION |
|
|
|
SESSION X Improving adherence to treatment |
|
|
Chairs |
Daria Podlekareva, University of Copenhagen, Denmark Igor Karpov, Belarus State Medical University, Belarus |
|
| Speakers |
Multidisciplinary approach to achieving optimal adherence to antiretroviral treatment for HIV-1 infection - experiences from Poland Adherence including a method to improve adherence in outpatient clinic Antiretroviral therapy (ART) among patients receiving care at the outpatient HIV clinic in East-Viru Central Hospital HIV infection in Saint-Petersburg and problems in achieving adherence to antiretroviral treatment |
|
|
|
SESSION XI HIV-testing policies and technologies |
|
|
Chair |
Nikos Dedes, Positive Voice, Greece/Civil Society Forum, Greece Johann Fontaine, Ministry of Health, Germany |
|
| Speakers |
Supporting HIV testing and counselling scale up in the WHO European Region Developing guidance for HIV testing - NICE's experience BCN checkpoint: the experience of a community based center for men who have sex with men in Barcelona shows high effectiveness in HIV detection HIV testing practices in Europe: the experience of HIV diagnosed patients |
|
|
14.30 - 20.00 |
||
| 08.30 - 13.30 | IQhiv Steering Group meeting. IQhiv Initiative (by invitation only) | |
| 12.30 - 14.30 | Meeting of the EU HIV/AIDS project coordinators. EAHC (by invitation only) | |
| 13.30 - 15.30 |
Workshop on the Civil Society Involvement into the Global Fund processes. EHRN |
|
| 14.00 - 18.00 | Wokshop on Stigma Index. GNP+ | |
| 16.00 - 20.00 | Workshop on Improving Early Access to HIV and STI Diagnostics and Referral to Treatment Services for Key-populations (BORDERNETWORK project). NIHD |
|
| 16.30 - 18.00 | IQhiv - Improving Quality in HIV Prevention in Europe. IQhiv Initiative |
|
| 09.00 - 19.00 | Open stage/Dialogue space | |
Friday, May 27th, 2011 |
||
|
09.00 - 10.30 |
PARALLEL SESSION |
|
|
|
SESSION XII Reproductive health and stigma |
|
|
Chairs |
Svilen Konov, European AIDS Treatment Group, United Kingdom Anastasia Solovyeva, International Treatment Preparedness Coalition, Russian Federation |
|
| Speakers |
Sexual and reproductive rights of people living with of HIV Developing a training and resource package for improving sexual and reproductive health of people living with HIV Findings from the PLHIV Stigma Index in Estonia Findings from the PLHIV Stigma Index in Ukraine |
|
|
|
SESSION XIII HIV in prison settings |
|
|
Chairs |
Signe Rotberga, UNODC, Project Office for the Baltic States Zaza Tsereteli, NDPHS, Primary Health and Prison Health Systems |
|
| Speakers |
Drug use, health consequences and interventions in prison in Europe Introduction of evidence-informed HIV prevention in prison settings in the new EU member states: challenges and lessons learned Results from the Spanish experience: A comprehensive approach to harm reduction programs in Spanish prisons The HIV- and HCV prevalence in selected Czech prisons: preliminary results from a pilot study Prison Health = Public Health? The ongoing loop of successes and challenges in HIV-related work in German Prisons |
|
|
10.30 - 11.00 |
Break |
|
|
11.00 - 13.00 |
PLENARY |
|
|
|
Is there a need for regional collaboration and coordination? |
|
|
Moderator |
Henning Mikkelsen, UNAIDS Brussels Office |
|
| Speaker | Is there a need for regional collaboration and coordination? Roger Drew, Health and Development Consultant, United Kingdom |
|
| Panelists |
Key-note presentation on different dimensions and aims of regional collaboration will be followed panel discusion on lesson learned and further cooperation possibilities. Panelists will include representatives of the national governments, international and civil society organizations. List of panelists to be confirmed soon. |
|
|
13.00 - 13.30 |
Break |
|
|
13.30 - 14.30 |
CLOSING SESSION |
|
| Chairs |
Wolfgang Philipp, The Directorate General Health and Consumers of the European Commission Denis Broun, UNAIDS Regional Support Team for Europe and Central Asia |
|
|
Speakers |
Main challenges in the field of HIV in the European region Main findings of the conference |
|
|
09.00 - 18.00 |
||
| 09.00 - 11.00 |
Satellite session on Launching advocacy campaign for HCV treatment access in the region of Eastern Europe and Central Asia (EECA): pricing, partnerships and community mobilization. EHRN |
|
| 10.30 - 11.30 | Open stage/Dialogue space | |
| 15.00 - 18.00 |
BorderNet WP6 Coordination Meeting. NIHD (by invitation) |
|